Annual Total Debt:
$910.01M-$24.73M(-2.65%)Summary
- As of today (September 16, 2025), RARE annual total debt is $910.01 million, with the most recent change of -$24.73 million (-2.65%) on December 31, 2024.
- During the last 3 years, RARE annual total debt has risen by +$516.25 million (+131.11%).
- RARE annual total debt is now -2.65% below its all-time high of $934.74 million, reached on December 31, 2023.
Performance
RARE Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$882.91M-$6.79M(-0.76%)Summary
- As of today (September 16, 2025), RARE quarterly total debt is $882.91 million, with the most recent change of -$6.79 million (-0.76%) on June 30, 2025.
- Over the past year, RARE quarterly total debt has dropped by -$43.63 million (-4.71%).
- RARE quarterly total debt is now -7.31% below its all-time high of $952.55 million, reached on September 30, 2023.
Performance
RARE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
RARE Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.6% | -4.7% |
3 y3 years | +131.1% | +122.7% |
5 y5 years | +158.3% | +139.0% |
RARE Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2.6% | +131.1% | -7.3% | +122.7% |
5 y | 5-year | -2.6% | +158.3% | -7.3% | +139.0% |
alltime | all time | -2.6% | >+9999.0% | -7.3% | >+9999.0% |
RARE Total debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $882.91M(-0.8%) |
Mar 2025 | - | $889.70M(-2.2%) |
Dec 2024 | $910.01M(-2.6%) | $910.01M(-0.3%) |
Sep 2024 | - | $912.50M(-1.5%) |
Jun 2024 | - | $926.54M(-0.6%) |
Mar 2024 | - | $932.17M(-0.3%) |
Dec 2023 | $934.74M(+3.1%) | $934.74M(-1.9%) |
Sep 2023 | - | $952.55M(+2.4%) |
Jun 2023 | - | $930.45M(+1.3%) |
Mar 2023 | - | $918.61M(+1.3%) |
Dec 2022 | $907.03M(+130.4%) | $907.03M(+1.1%) |
Sep 2022 | - | $896.75M(+126.2%) |
Jun 2022 | - | $396.48M(+0.4%) |
Mar 2022 | - | $395.00M(+0.3%) |
Dec 2021 | $393.76M(+2.6%) | $393.76M(+0.4%) |
Sep 2021 | - | $392.12M(+0.5%) |
Jun 2021 | - | $390.20M(+1.0%) |
Mar 2021 | - | $386.34M(+0.6%) |
Dec 2020 | $383.89M(+8.9%) | $383.89M(+2.2%) |
Sep 2020 | - | $375.49M(+1.7%) |
Jun 2020 | - | $369.35M(+1.7%) |
Mar 2020 | - | $363.28M(+3.1%) |
Dec 2019 | $352.36M(>+9900.0%) | $352.36M(+815.3%) |
Sep 2019 | - | $38.50M(-3.7%) |
Jun 2019 | - | $39.97M(+41.5%) |
Mar 2019 | - | $28.24M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00 |
Dec 2011 | $0.00 | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total debt?
- What is the all time high annual total debt for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual total debt year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total debt?
- What is the all time high quarterly total debt for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly total debt year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total debt?
The current annual total debt of RARE is $910.01M
What is the all time high annual total debt for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total debt is $934.74M
What is Ultragenyx Pharmaceutical Inc. annual total debt year-on-year change?
Over the past year, RARE annual total debt has changed by -$24.73M (-2.65%)
What is Ultragenyx Pharmaceutical Inc. quarterly total debt?
The current quarterly total debt of RARE is $882.91M
What is the all time high quarterly total debt for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total debt is $952.55M
What is Ultragenyx Pharmaceutical Inc. quarterly total debt year-on-year change?
Over the past year, RARE quarterly total debt has changed by -$43.63M (-4.71%)